toggle visibility Search & Display Options

Select All    Deselect All
 |   | 
Details
   print
  Record Links
Author (up) Kraus, M.A.; Kansal, S.; Copland, M.; Komenda, P.; Weinhandl, E.D.; Bakris, G.L.; Chan, C.T.; Fluck, R.J.; Burkart, J.M. url  doi
openurl 
  Title Intensive Hemodialysis and Potential Risks With Increasing Treatment Type Journal Article
  Year 2016 Publication American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation Abbreviated Journal Am J Kidney Dis  
  Volume 68 Issue 5s1 Pages S51-S58  
  Keywords Arteriovenous Shunt, Surgical/adverse effects; Catheterization, Central Venous/adverse effects; Humans; Infection/etiology; Kidney/physiopathology; Kidney Failure, Chronic/mortality/physiopathology/*therapy; Renal Dialysis/*adverse effects/*methods; Risk Factors; *Buttonhole cannulation; *Frequent Hemodialysis Network; *caregiver; *chronic kidney disease; *daily dialysis; *end stage renal disease (ESRD); *home dialysis; *infection; *intensive hemodialysis; *mortality; *nocturnal hemodialysis; *residual renal function; *review; *short daily hemodialysis; *survival; *technique failure; *vascular access  
  Abstract Although intensive hemodialysis (HD) can address important clinical problems, increasing treatment also introduces risks. In this review, we assess risks pertaining to 6 domains: vascular access complications, infection, mortality, loss of residual kidney function, solute balance, and patient and care partner burden. In the Frequent Hemodialysis Network (FHN) trials, short daily and nocturnal schedules increased the incidence of access complications, although the incidence of access loss was not statistically higher. Observational studies indicate that infection-related hospitalization is an ongoing challenge with short daily HD. Excess risk may be catalyzed by poor infection control practices in the home setting in which intensive HD is typically delivered, but with fixed probability of bacterial contamination per cannulation, greater treatment frequency necessarily increases the risk for infectious complications. Buttonhole cannulation may increase the risk for metastatic infections. However, intensive HD in the home setting is associated with lower risk for infection than peritoneal dialysis. Data regarding mortality are equivocal. With extended follow-up of individuals in the FHN trials, short daily HD was associated with lower risk relative to the usual schedule, whereas nocturnal HD was associated with higher risk. In many, but not all, observational studies, short daily HD has been associated with lower risk than both in-center HD and peritoneal dialysis; however, observational studies are subject to unmeasured confounding. Intensive HD can accelerate the loss of residual kidney function in new dialysis patients with substantial urine output and can deplete solutes (eg, phosphorus) to the extent that supplementation is necessary. Finally, intensive HD may increase burden on patients and caregivers, possibly leading to technique failure. Some of these problems might be addressed with careful monitoring, so that relevant interventions (eg, antibiotics, retraining, and respite care) can be delivered. Ultimately, intensive HD is not a panacea for end-stage renal disease. Potential benefits and risks of treatment should be jointly considered.  
  Address Wake Forest University Medical Center, Winston-Salem, NC  
  Corporate Author Thesis  
  Publisher Place of Publication Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 0272-6386 ISBN Medium  
  Area Expedition Conference  
  Notes PMID:27772644 Approved no  
  Call Number ref @ user @ Serial 99016  
Permanent link to this record
Select All    Deselect All
 |   | 
Details
   print

Save Citations:
Export Records: